Ftse Mib
36.429,72
0,00%
DAX
21.727,20
0,48%
S&P 500
6.071,17
0,53%
NASDAQ
19.681,75
0,25%
Bitcoin
104.572,86
-0,15%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Veru Inc (VERU) Veru Inc (VERU) Notizie

Veru Inc

VERU
0,576
-0,0352 (-5,76%)
31 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202519:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/1/202519:14EDGAR2Form DEF 14A - Other definitive proxy statements
27/1/202512:30GLOBEVeru Announces Positive Topline Data from Phase 2b QUALITY..
31/12/202414:30GLOBEVeru Announces the Sale of the FC2 Female Condom® (Internal..
17/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16/12/202421:48EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/12/202418:07EDGAR2Form POS AM - Post-Effective amendments for registration..
26/11/202414:30GLOBEVeru to Present at the 17th International Conference of the..
12/11/202415:34EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
05/11/202414:30GLOBEVeru Announces Meta-analysis of Body Composition Data from..
04/11/202422:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
21/10/202414:30GLOBEVeru to Present at ObesityWeek: Meta-Analysis of 4 Previous..
16/10/202414:30GLOBEVeru to Deliver Keynote Presentation on the Scientific..
02/10/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202422:11EDGAR2Form 8-K - Current report
11/9/202414:30GLOBEVeru to Present at the 2024 Cantor Global Healthcare..
30/8/202422:08EDGAR2Form 8-K - Current report
23/8/202422:05EDGAR2Form 8-K - Current report
08/8/202416:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:01EDGAR2Form 8-K - Current report
08/8/202412:30GLOBEVeru Reaches Full Enrollment for Phase 2b QUALITY Clinical..
07/8/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202421:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202421:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202421:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202421:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202422:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/8/202422:07EDGAR2Form 8-K - Current report
01/8/202414:30GLOBEVeru to Report Fiscal 2024 Third Quarter Financial Results..
29/7/202414:30GLOBEVeru to Participate in the BTIG Virtual Biotechnology..
02/7/202414:30GLOBEVeru to Participate in the Leerink Therapeutics Forum: I&I..
24/6/202414:30GLOBEVeru Announces Safety and Body Composition Data from Two..
20/6/202413:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/6/202422:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/6/202422:05GLOBEVeru Adjourns 2024 Annual Meeting of Shareholders to June..
17/6/202422:45GLOBEVeru Reminds Shareholders to Vote in Advance of Tomorrow’s..
10/6/202414:30GLOBEVeru to Present at the American Diabetes Association's 84th..
28/5/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:10EDGAR2Form 8-K - Current report
22/5/202414:30GLOBEVeru to Present at the Jefferies Global Healthcare..
18/5/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202414:30GLOBEVeru Announces Steven B. Heymsfield M.D. as the Principal..
14/5/202414:30GLOBEVeru Announces Mitchell Steiner as Keynote Speaker at Biomed..
09/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,60 Min: 0,5522 Max: 0,614
Chiusura: 0,6112

La tua Cronologia

NASDAQ
VERU
Veru
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci